PharmD Live operates a telehealth platform centred on clinical pharmacists delivering medication management and chronic care services. The company integrates AI-driven predictive analytics with remote patient monitoring, pharmacogenomics, and medication therapy management across multiple care settings including transitional care. Its technology infrastructure encompasses EHR integration and remote monitoring capabilities, underpinned by full compliance with healthcare privacy requirements.
The company serves physicians, accountable care organisations, integrated delivery networks, health systems, and payors across the United States through a nationwide network of clinical pharmacists. This partnership-oriented model positions PharmD Live within the value-based care framework, where outcomes and cost control drive reimbursement structures rather than volume of services.
The healthcare landscape motivating the company's approach reflects persistent challenges: adverse drug events rank as the fourth leading cause of death in the US, with annual mortality exceeding 100,000 and associated costs reaching $500 billion yearly. Additionally, approximately 50% of medications are not taken as directed, whilst chronic disease management expenses are projected to exceed $5.4 trillion. These pressures have prompted health systems and payors to engage clinical pharmacists in more autonomous roles, addressing both medication safety and cost reduction alongside physician capacity constraints.